| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,042,274 | 1,042,274 | 1,063,409 | 1,473,958 | 766,571 |
| Cost of Revenue
|
-690,232 | -690,232 | -706,007 | -1,055,406 | -551,373 |
|
Gross Profit
|
352,042 | 352,042 | 357,402 | 418,552 | 215,198 |
| Selling, General and Administrative Expenses
|
-156,926 | -156,926 | -160,775 | -193,293 | -103,707 |
|
Research and Development Expenses
|
-175,434 | -175,434 | -168,616 | -157,543 | -79,868 |
|
Operating Income/Expenses
|
-332,360 | -332,360 | -329,391 | -350,836 | -183,575 |
|
Total Operating Profit/Loss
|
19,682 | 19,682 | 28,011 | 67,716 | 31,623 |
| Total Net Finance Income/Expense
|
-1,848 | -1,848 | -1,624 | -893 | 63 |
|
Other Income/Expense, Non-Operating
|
-5,332 | -5,332 | 3,531 | 3,478 | 4,130 |
|
Non-Operating Income/Expenses, Total
|
-7,180 | -7,180 | 1,907 | 2,585 | 4,193 |
|
Pretax Income
|
12,502 | 12,502 | 29,918 | 70,301 | 35,816 |
|
Provision for Income Tax
|
-2,647 | -2,647 | 10,167 | 7,880 | 595 |
|
Net Income from Continuing Operations
|
9,855 | 9,855 | 40,085 | 78,181 | 36,411 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
9,855 | 9,855 | 40,085 | 78,181 | 36,411 |
|
Non-Controlling/Minority Interests
|
-73 | -73 | -296 | -513 | -269 |
|
Net Income after Non-Controlling/Minority Interests
|
9,782 | 9,782 | 39,789 | 77,668 | 36,142 |
| Preferred/Other Stock Distribution
|
-- | -- | -- | 0 | 0 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
0 | -- | 0 | 0 | -2,906 |
|
Net Income Available to Common Stockholders
|
9,782 | 9,782 | 39,789 | 77,668 | 33,236 |
|
Diluted Net Income Available to Common Stockholders
|
9,782 | 9,782 | 39,789 | 77,668 | 33,236 |
| Basic EPS
|
507.50 | 507.50 | 2.51k | 4.88k | 2.09k |
| Diluted EPS
|
507.50 | 507.50 | 2.51k | 4.88k | 2.09k |
|
Basic Weighted Average Shares Outstanding
|
19.2760 | 19.2760 | 15.8580 | 15.9130 | 15.9130 |
|
Diluted Weighted Average Shares Outstanding
|
19.2760 | 19.2760 | 15.8580 | 15.9130 | 15.9130 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
25,023 | 14,350 | 31,542 | 71,194 | 35,753 |
|
EBITDA
|
42,499 | 27,911 | 40,389 | 76,202 | 39,746 |
|
Normalized EBITDA
|
42,549 | 27,910 | 39,395 | 76,202 | 39,246 |
|
Normalized Income
|
8,268 | 9,854.2117 | 39,091 | 78,181 | 35,911 |
|
Total Unusual Items
|
50 | -1 | -994 | 0 | -500 |
12/31/2022 - 3/5/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade